Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $185.22 million. The enterprise value is $71.07 million.
Important Dates
The next estimated earnings date is Friday, May 8, 2026, after market close.
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CRBU has 98.26 million shares outstanding. The number of shares has increased by 3.40% in one year.
| Current Share Class | 98.26M |
| Shares Outstanding | 98.26M |
| Shares Change (YoY) | +3.40% |
| Shares Change (QoQ) | +1.33% |
| Owned by Insiders (%) | 4.45% |
| Owned by Institutions (%) | 40.62% |
| Float | 93.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.73 |
| Forward PS | 7.13 |
| PB Ratio | 1.52 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.71, with a Debt / Equity ratio of 0.22.
| Current Ratio | 5.71 |
| Quick Ratio | 5.60 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -78.97% and return on invested capital (ROIC) is -39.03%.
| Return on Equity (ROE) | -78.97% |
| Return on Assets (ROA) | -34.26% |
| Return on Invested Capital (ROIC) | -39.03% |
| Return on Capital Employed (ROCE) | -89.31% |
| Weighted Average Cost of Capital (WACC) | 14.62% |
| Revenue Per Employee | $115,041 |
| Profits Per Employee | -$1.53M |
| Employee Count | 97 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -550,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +149.90% in the last 52 weeks. The beta is 2.27, so CRBU's price volatility has been higher than the market average.
| Beta (5Y) | 2.27 |
| 52-Week Price Change | +149.90% |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 42.99 |
| Average Volume (20 Days) | 1,509,552 |
Short Selling Information
The latest short interest is 6.77 million, so 6.89% of the outstanding shares have been sold short.
| Short Interest | 6.77M |
| Short Previous Month | 6.47M |
| Short % of Shares Out | 6.89% |
| Short % of Float | 7.21% |
| Short Ratio (days to cover) | 5.85 |
Income Statement
In the last 12 months, CRBU had revenue of $11.16 million and -$148.13 million in losses. Loss per share was -$1.59.
| Revenue | 11.16M |
| Gross Profit | -96.36M |
| Operating Income | -133.92M |
| Pretax Income | -148.68M |
| Net Income | -148.13M |
| EBITDA | -130.27M |
| EBIT | -133.92M |
| Loss Per Share | -$1.59 |
Full Income StatementBalance Sheet
The company has $139.34 million in cash and $27.23 million in debt, with a net cash position of $115.62 million or $1.18 per share.
| Cash & Cash Equivalents | 139.34M |
| Total Debt | 27.23M |
| Net Cash | 115.62M |
| Net Cash Per Share | $1.18 |
| Equity (Book Value) | 122.18M |
| Book Value Per Share | 1.28 |
| Working Capital | 119.82M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$110.99 million and capital expenditures -$1.36 million, giving a free cash flow of -$112.35 million.
| Operating Cash Flow | -110.99M |
| Capital Expenditures | -1.36M |
| Depreciation & Amortization | 3.65M |
| Net Borrowing | n/a |
| Free Cash Flow | -112.35M |
| FCF Per Share | -$1.14 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,200.09% |
| Pretax Margin | -1,332.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CRBU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.40% |
| Shareholder Yield | -3.40% |
| Earnings Yield | -79.34% |
| FCF Yield | -60.18% |
Analyst Forecast
The average price target for CRBU is $10.75, which is 470.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.75 |
| Price Target Difference | 470.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 134.93% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CRBU has an Altman Z-Score of -4.75 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.75 |
| Piotroski F-Score | 3 |
